Navigation Links
Tengion to Present at 27th Annual JP Morgan Healthcare Conference

Completed Phase 2 Bladder Augment Trial and Plans for Registration Trial to be Discussed

Breakthrough in Kidney Regeneration Program: Preclinical Progress to be Highlighted

EAST NORRITON, Pa., Jan. 6 /PRNewswire/ -- Tengion Inc., a clinical-stage organ regeneration company with products in urologic, vascular, and renal regeneration, today announced that Steven Nichtberger, M.D., president and chief executive officer, is scheduled to present at the 27th Annual JP Morgan Healthcare Conference on Monday, January 12, 2009 at 2:30 p.m. PST. The conference will be held January 12 - 15 at The Westin St. Francis Hotel in San Francisco.

For the first time, Dr. Nichtberger will discuss Tengion's completion of its Phase 2 clinical trial in patients with neurogenic bladder due to spina bifida and the company's plans for a Phase 3 trial of its Tengion Neo-Bladder Augment(R) in patients with neurogenic bladder, planned for initiation in the first half of 2009. Dr. Nichtberger will also present breakthrough preclinical data from Tengion's renal program.

"Regenerative medicine is on the verge of unimagined breakthroughs. Similar to the emergence of novel chemical, protein, and antibody therapeutics in the past few decades, the impact of regenerative medicine on human health is emerging with great promise in the new millennium," said Dr. Nichtberger. "Tengion is at the forefront of this space with a practical and proven organ regeneration technology platform with nearly a decade of human clinical experience. Recent preclinical advances in our renal program, which is focused on eliminating the need for dialysis in patients with emerging kidney failure, reinforce the promise and value of our technology platform. The past year has been filled with important milestones that position us well for 2009."

"Kidney regeneration from patients' own cells would become the standard of care for chronic renal failure therapy. Tengion's work on the neo-kidney is an important early step towards this goal," said Brian Pereira, MD, former President of the National Kidney Foundation, editor of the leading textbook, "Chronic Kidney Disease, Dialysis, & Transplantation," and Board member of Tengion, Inc.

About Tengion

Tengion is a clinical-stage organ regeneration company with products in urologic, vascular and renal regeneration based on its proprietary Autologous Organ Regeneration Platform(TM). Tengion uses biocompatible materials and a patient's own (autologous) cells to create neo-organs or neo-tissues that are designed to catalyze the body's innate ability to regenerate. Tengion is a fully-integrated organization, with scalable U.S. and European manufacturing and distribution capabilities, experienced research, development, clinical and commercial teams, and significant intellectual property. Tengion's product candidates may ultimately address the most critical problems facing organ and tissue failure patients, enabling people to lead healthier lives without donor transplants or the side effects of related therapies. For more information, please visit

SOURCE Tengion
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology: